期刊
MEDICINE
卷 101, 期 45, 页码 -出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MD.0000000000031705
关键词
BRCA2; breast cancer; ovarian cancer; PRAP inhibitor; prostate cancer
资金
- National Natural Science Foundation of China [81870683, 82121003]
- Department of Science and Technology of Sichuan Province [2020JDTD0028, 2022YFS0606, 22ZYZYTS0151]
- CAMS Innovation Fund for Medical Sciences [2019-12M-5-032]
Breast cancer susceptibility gene 2 (BRCA2) is the main gene associated with hereditary breast cancers, but mutations in BRCA2 are also found in other types of tumors. This review discusses the biological functions of BRCA2 and the role of BRCA2 mutations in tumor progression and therapy.
Breast cancer susceptibility gene 2 (BRCA2) is the main gene associated with hereditary breast cancers. However, a mutation in BRCA2 has also been found in other tumors, such as ovarian, pancreatic, thyroid, gastric, laryngeal, and prostate cancers. In this review, we discuss the biological functions of BRCA2 and the role of BRCA2 mutations in tumor progression and therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据